HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Nancy Pryer Selected Research
Nancy Pryer Research Topics
Disease
5
Neoplasms (Cancer)
01/2018 - 03/2007
2
Breast Neoplasms (Breast Cancer)
11/2014 - 12/2013
2
Carcinogenesis
04/2014 - 12/2013
1
Disease Progression
12/2019
1
Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis)
12/2019
1
Carcinoma (Carcinomatosis)
11/2014
1
Keratoacanthoma
04/2014
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2014
1
Adenocarcinoma
03/2007
Drug/Important Bio-Agent (IBA)
1
Tripeptidyl-Peptidase 1
IBA
12/2019
1
Enzymes
IBA
12/2019
1
Biomarkers (Surrogate Marker)
IBA
12/2019
1
Sunitinib (Sutent)
FDA Link
01/2018
1
Immunoconjugates (Immunoconjugate)
IBA
01/2018
1
Imatinib Mesylate (Gleevec)
FDA Link
01/2018
1
regorafenib
IBA
01/2018
1
Macrophage Colony-Stimulating Factor
IBA
11/2014
1
Carboplatin (JM8)
FDA Link
Generic
11/2014
1
Interleukin-10 (Interleukin 10)
IBA
11/2014
1
Paclitaxel (Taxol)
FDA Link
Generic
11/2014
1
Interleukin-10 Receptors
IBA
11/2014
1
Vemurafenib
IBA
04/2014
1
Mitogen-Activated Protein Kinases
IBA
04/2014
1
DNA (Deoxyribonucleic Acid)
IBA
04/2014
1
Keratins (Keratin)
IBA
12/2013
1
4- (2- (2- hydroxycyclohexylamino)benzothiazol- 6- yloxy)pyridine- 2- carboxylic acid methylamide
IBA
12/2013
1
Tumor Viral Antigens (Large T Antigen)
IBA
12/2013
1
Carbohydrates
IBA
03/2007
1
Antigens
IBA
03/2007
1
RAAG12
IBA
03/2007
1
Monoclonal Antibodies
IBA
03/2007
Therapy/Procedure
1
Drug Therapy (Chemotherapy)
11/2014